ESR1 and central nervous system cancer: Moreover, Gremlin 1 was identified as a promoter of stem cell maintenance in glioma and colorectal cancer [30,31], and the upregulation of Gremlin 1 significantly correlated with stem cell marker expression and poor survival in estrogen receptor (ER)-negative breast cancer patients [8].